Psychology Department, University of Minnesota.
Psychiatry Department, The Ohio State University.
J Psychopathol Clin Sci. 2024 Nov;133(8):697-715. doi: 10.1037/abn0000903.
Understanding the neurobiological mechanisms involved in psychopathology has been hindered by the limitations of categorical nosologies. The Hierarchical Taxonomy of Psychopathology (HiTOP) is an alternative dimensional system for characterizing psychopathology, derived from quantitative studies of covariation among diagnoses and symptoms. HiTOP provides more promising targets for clinical neuroscience than traditional psychiatric diagnoses and can facilitate cumulative integration of existing research. We systematically reviewed 164 human neuroimaging studies with sample sizes of 194 or greater that have investigated dimensions of psychopathology classified within HiTOP. Replicated results were identified for constructs at five different levels of the hierarchy, including the overarching p-factor, the externalizing superspectrum, the thought disorder and internalizing spectra, the distress subfactor, and the depression symptom dimension. Our review highlights the potential of dimensional clinical neuroscience research and the usefulness of HiTOP while also suggesting limitations of existing work in this relatively young field. We discuss how HiTOP can be integrated synergistically with neuroscience-oriented, transdiagnostic frameworks developed by the National Institutes of Health, including the Research Domain Criteria, Addictions Neuroclinical Assessment, and the National Institute on Drug Abuse's Phenotyping Assessment Battery, and how researchers can use HiTOP to accelerate clinical neuroscience research in humans and other species. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
理解精神病理学中涉及的神经生物学机制一直受到分类病理学的限制。精神病理学的分层分类法(HiTOP)是一种用于描述精神病理学的替代维度系统,它源自对诊断和症状之间的共变进行定量研究。与传统的精神诊断相比,HiTOP 为临床神经科学提供了更有希望的目标,并可以促进现有研究的累积整合。我们系统地回顾了 164 项人类神经影像学研究,这些研究的样本量为 194 或更多,研究了 HiTOP 中分类的精神病理学维度。在五个不同层次的结构中,包括总体 p 因素、外在超谱、思维障碍和内在谱、痛苦子因素和抑郁症状维度,都确定了可重复的结果。我们的综述强调了维度临床神经科学研究的潜力和 HiTOP 的有用性,同时也指出了这个相对年轻领域现有工作的局限性。我们讨论了如何将 HiTOP 与美国国立卫生研究院开发的以神经科学为导向、跨诊断的框架(包括研究领域标准、成瘾神经临床评估和国家药物滥用研究所的表型评估电池)协同整合,以及研究人员如何利用 HiTOP 加速人类和其他物种的临床神经科学研究。(PsycInfo 数据库记录(c)2024 APA,保留所有权利)。